LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision
The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn’t been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)− 485–5p/ heat shock protein 90 (HSP90) axis, clinically. qRT...
Saved in:
Published in | Pathology, research and practice Vol. 247; p. 154570 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Elsevier GmbH
01.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn’t been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)− 485–5p/ heat shock protein 90 (HSP90) axis, clinically. qRT-PCR was performed to detect lncRNA NNT-AS1 and hsa-miR-485–5p expression levels in 60 Egyptian patients' sera. HSP90 serum level was quantified using Enzyme-linked immunosorbent assay (ELISA). The relative expression level of the studied non-coding RNAs as well as the HSP90 ELISA concentration were correlated with patients clinicopathological characteristics and correlated to each other. The axis diagnostic utility in comparison with carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen (CEA) tumor markers (TMs) was studied by receiver operating characteristic (ROC) curve analysis. The relative lncRNA NNT-AS1 expression level fold change 56.7 (13.5–112) and HSP90 protein ELISA level 6.68 (5.14–8.77) (ng/mL) were elevated, while, for hsa-miR-485–5p 0.0474 (0.0236–0.135) expression fold change was repressed in CRC Egyptian patients’ cohort sera, being compared to 28 apparently healthy control subjects. LncRNA NNT-AS1 specificity is 96.4% and a sensitivity of 91.7%, hsa-miR-485–5p showed 96.4% specificity, 90% sensitivity, and for HSP90 89.3%, 70% specificity and sensitivity, respectively. Those specificities and sensitivities were superior to the classical CRC TMs. A significant negative correlation was found between hsa-miR-485–5p with lncRNA NNT-AS1 (r = −0.933) expression fold change or with HSP90 protein blood level (r = −0.997), but, significant positive correlation was there between lncRNA NNT-AS1 and HSP90 (r = 0.927). LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis could be a prospect for CRC development as well as diagnosis. Being correlated and related to CRC histologic grades 1–3, therefore, lncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis (not individually) expression approved clinically and in silico, could aid treatment precision.
[Display omitted] |
---|---|
AbstractList | The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn't been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)- 485-5p/ heat shock protein 90 (HSP90) axis, clinically. qRT-PCR was performed to detect lncRNA NNT-AS1 and hsa-miR-485-5p expression levels in 60 Egyptian patients' sera. HSP90 serum level was quantified using Enzyme-linked immunosorbent assay (ELISA). The relative expression level of the studied non-coding RNAs as well as the HSP90 ELISA concentration were correlated with patients clinicopathological characteristics and correlated to each other. The axis diagnostic utility in comparison with carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) tumor markers (TMs) was studied by receiver operating characteristic (ROC) curve analysis. The relative lncRNA NNT-AS1 expression level fold change 56.7 (13.5-112) and HSP90 protein ELISA level 6.68 (5.14-8.77) (ng/mL) were elevated, while, for hsa-miR-485-5p 0.0474 (0.0236-0.135) expression fold change was repressed in CRC Egyptian patients' cohort sera, being compared to 28 apparently healthy control subjects. LncRNA NNT-AS1 specificity is 96.4% and a sensitivity of 91.7%, hsa-miR-485-5p showed 96.4% specificity, 90% sensitivity, and for HSP90 89.3%, 70% specificity and sensitivity, respectively. Those specificities and sensitivities were superior to the classical CRC TMs. A significant negative correlation was found between hsa-miR-485-5p with lncRNA NNT-AS1 (r = -0.933) expression fold change or with HSP90 protein blood level (r = -0.997), but, significant positive correlation was there between lncRNA NNT-AS1 and HSP90 (r = 0.927). LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis could be a prospect for CRC development as well as diagnosis. Being correlated and related to CRC histologic grades 1-3, therefore, lncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis (not individually) expression approved clinically and in silico, could aid treatment precision. The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn’t been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)− 485–5p/ heat shock protein 90 (HSP90) axis, clinically. qRT-PCR was performed to detect lncRNA NNT-AS1 and hsa-miR-485–5p expression levels in 60 Egyptian patients' sera. HSP90 serum level was quantified using Enzyme-linked immunosorbent assay (ELISA). The relative expression level of the studied non-coding RNAs as well as the HSP90 ELISA concentration were correlated with patients clinicopathological characteristics and correlated to each other. The axis diagnostic utility in comparison with carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen (CEA) tumor markers (TMs) was studied by receiver operating characteristic (ROC) curve analysis. The relative lncRNA NNT-AS1 expression level fold change 56.7 (13.5–112) and HSP90 protein ELISA level 6.68 (5.14–8.77) (ng/mL) were elevated, while, for hsa-miR-485–5p 0.0474 (0.0236–0.135) expression fold change was repressed in CRC Egyptian patients’ cohort sera, being compared to 28 apparently healthy control subjects. LncRNA NNT-AS1 specificity is 96.4% and a sensitivity of 91.7%, hsa-miR-485–5p showed 96.4% specificity, 90% sensitivity, and for HSP90 89.3%, 70% specificity and sensitivity, respectively. Those specificities and sensitivities were superior to the classical CRC TMs. A significant negative correlation was found between hsa-miR-485–5p with lncRNA NNT-AS1 (r = −0.933) expression fold change or with HSP90 protein blood level (r = −0.997), but, significant positive correlation was there between lncRNA NNT-AS1 and HSP90 (r = 0.927). LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis could be a prospect for CRC development as well as diagnosis. Being correlated and related to CRC histologic grades 1–3, therefore, lncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis (not individually) expression approved clinically and in silico, could aid treatment precision. [Display omitted] The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn't been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)- 485-5p/ heat shock protein 90 (HSP90) axis, clinically. qRT-PCR was performed to detect lncRNA NNT-AS1 and hsa-miR-485-5p expression levels in 60 Egyptian patients' sera. HSP90 serum level was quantified using Enzyme-linked immunosorbent assay (ELISA). The relative expression level of the studied non-coding RNAs as well as the HSP90 ELISA concentration were correlated with patients clinicopathological characteristics and correlated to each other. The axis diagnostic utility in comparison with carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) tumor markers (TMs) was studied by receiver operating characteristic (ROC) curve analysis. The relative lncRNA NNT-AS1 expression level fold change 56.7 (13.5-112) and HSP90 protein ELISA level 6.68 (5.14-8.77) (ng/mL) were elevated, while, for hsa-miR-485-5p 0.0474 (0.0236-0.135) expression fold change was repressed in CRC Egyptian patients' cohort sera, being compared to 28 apparently healthy control subjects. LncRNA NNT-AS1 specificity is 96.4% and a sensitivity of 91.7%, hsa-miR-485-5p showed 96.4% specificity, 90% sensitivity, and for HSP90 89.3%, 70% specificity and sensitivity, respectively. Those specificities and sensitivities were superior to the classical CRC TMs. A significant negative correlation was found between hsa-miR-485-5p with lncRNA NNT-AS1 (r = -0.933) expression fold change or with HSP90 protein blood level (r = -0.997), but, significant positive correlation was there between lncRNA NNT-AS1 and HSP90 (r = 0.927). LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis could be a prospect for CRC development as well as diagnosis. Being correlated and related to CRC histologic grades 1-3, therefore, lncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis (not individually) expression approved clinically and in silico, could aid treatment precision.The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn't been sufficiently inspected in relation to the Homo sapiens (hsa)-microRNA (miR)- 485-5p/ heat shock protein 90 (HSP90) axis, clinically. qRT-PCR was performed to detect lncRNA NNT-AS1 and hsa-miR-485-5p expression levels in 60 Egyptian patients' sera. HSP90 serum level was quantified using Enzyme-linked immunosorbent assay (ELISA). The relative expression level of the studied non-coding RNAs as well as the HSP90 ELISA concentration were correlated with patients clinicopathological characteristics and correlated to each other. The axis diagnostic utility in comparison with carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) tumor markers (TMs) was studied by receiver operating characteristic (ROC) curve analysis. The relative lncRNA NNT-AS1 expression level fold change 56.7 (13.5-112) and HSP90 protein ELISA level 6.68 (5.14-8.77) (ng/mL) were elevated, while, for hsa-miR-485-5p 0.0474 (0.0236-0.135) expression fold change was repressed in CRC Egyptian patients' cohort sera, being compared to 28 apparently healthy control subjects. LncRNA NNT-AS1 specificity is 96.4% and a sensitivity of 91.7%, hsa-miR-485-5p showed 96.4% specificity, 90% sensitivity, and for HSP90 89.3%, 70% specificity and sensitivity, respectively. Those specificities and sensitivities were superior to the classical CRC TMs. A significant negative correlation was found between hsa-miR-485-5p with lncRNA NNT-AS1 (r = -0.933) expression fold change or with HSP90 protein blood level (r = -0.997), but, significant positive correlation was there between lncRNA NNT-AS1 and HSP90 (r = 0.927). LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis could be a prospect for CRC development as well as diagnosis. Being correlated and related to CRC histologic grades 1-3, therefore, lncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis (not individually) expression approved clinically and in silico, could aid treatment precision. |
ArticleNumber | 154570 |
Author | Wasfey, Eman F. Hamdy, Nadia M. Fawzy, Amal El-Sheikh, Nada M. Abulsoud, Ahmed I. |
Author_xml | – sequence: 1 givenname: Nada M. surname: El-Sheikh fullname: El-Sheikh, Nada M. organization: Biochemistry Department, Faculty of Pharmacy, Heliopolis University, El Salam City, 11785 Cairo, Egypt – sequence: 2 givenname: Ahmed I. surname: Abulsoud fullname: Abulsoud, Ahmed I. organization: Biochemistry Department, Faculty of Pharmacy, Heliopolis University, El Salam City, 11785 Cairo, Egypt – sequence: 3 givenname: Amal surname: Fawzy fullname: Fawzy, Amal organization: Department of Clinical and Chemical Pathology, National Cancer Institute, Cairo University, 11796 Cairo, Egypt – sequence: 4 givenname: Eman F. surname: Wasfey fullname: Wasfey, Eman F. organization: Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, 11566 Cairo, Egypt – sequence: 5 givenname: Nadia M. surname: Hamdy fullname: Hamdy, Nadia M. email: nadia_hamdy@pharma.asu.edu.eg organization: Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, 11566 Cairo, Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37244051$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctuEzEUhi3UiqaBB2CDvGTj5HjsuRhWUQQUKUqrtKxHHvukdTQZD7bDZcc78AY8Gk-CSwoLFl1ZOv6_I_v7z8nJ4Ack5AWHGQdezXezMYyzAgox46Usa3hCJrziDYNK8BMyASElAyGaM3Ie4w4AapD8KTkTdSEllHxCfq4Gs1kv6Hp9wxbXfH4XNdu7DZNN-ev7j3KcX1xfKaD6q4vUDSy63hlP9WCp6d3gjO7pGHwc0SRqfAjY64SWJU_vXEy-97fO0NugLUbW6YiWLjdLGlPQyW0znpwfXtNFnuBIk_-ig6XHF10FNC7m62fkdKv7iM8fzin5-O7tzfKCrS7ff1guVsyIUiRWaquU6rSUuFXYgREooBFKdpLXlal1VTeqAcuV2oIC6AqE0tqys0Unq2xpSl4d9-YPfTpgTO3eRYN9rwf0h9gWTQFQ1CovnZKXD9FDt0fbjsHtdfjW_vWaA_wYMFlODLj9F-HQ3nfX7vJkbO-7a4_dZab-jzEu_RGUbbn-UfLNkcSs57PD0EbjcDBoXZaYWuvdI_Rvmfmy9g |
CitedBy_id | crossref_primary_10_1016_j_prp_2023_154684 crossref_primary_10_1016_j_prp_2023_154665 crossref_primary_10_1089_dna_2023_0172 crossref_primary_10_1016_j_ijbiomac_2023_128722 crossref_primary_10_1016_j_prp_2023_154763 crossref_primary_10_7555_JBR_38_20240190 crossref_primary_10_1016_j_ijbiomac_2024_130468 crossref_primary_10_1002_jbt_23774 crossref_primary_10_3892_ol_2024_14619 crossref_primary_10_3390_ncrna9050058 crossref_primary_10_1016_j_prp_2023_155054 crossref_primary_10_1016_j_lfs_2024_122946 crossref_primary_10_1016_j_prp_2023_154682 crossref_primary_10_1016_j_prp_2023_154880 crossref_primary_10_3389_fragi_2024_1373741 crossref_primary_10_1016_j_prp_2024_155093 crossref_primary_10_1080_08820139_2024_2309557 crossref_primary_10_1016_j_prp_2023_154715 crossref_primary_10_1016_j_microc_2025_113330 crossref_primary_10_1016_j_prp_2023_154817 crossref_primary_10_1016_j_prp_2023_155027 crossref_primary_10_1016_j_intimp_2024_113309 crossref_primary_10_1016_j_prp_2024_155125 crossref_primary_10_1016_j_prp_2023_154856 crossref_primary_10_1016_j_prp_2023_155007 crossref_primary_10_1016_j_lfs_2024_122850 crossref_primary_10_1016_j_prp_2023_155085 crossref_primary_10_1016_j_prp_2023_154690 crossref_primary_10_1177_11772719241258642 crossref_primary_10_1016_j_prp_2023_155023 crossref_primary_10_1016_j_prp_2024_155102 crossref_primary_10_1016_j_prp_2023_154790 crossref_primary_10_1016_j_prp_2023_154771 crossref_primary_10_1016_j_prp_2024_155187 crossref_primary_10_1016_j_prp_2023_154704 crossref_primary_10_1111_febs_17253 crossref_primary_10_1007_s00210_024_03308_z crossref_primary_10_1016_j_yexcr_2024_114272 crossref_primary_10_1016_j_prp_2023_154947 crossref_primary_10_3389_fonc_2024_1419972 crossref_primary_10_1016_j_prp_2023_154949 |
Cites_doi | 10.1093/nar/gkac888 10.1007/s11894-019-0703-8 10.1186/s12943-022-01556-2 10.1186/s12885-019-5663-8 10.1016/j.prp.2022.154183 10.1038/cddis.2016.27 10.1101/cshperspect.a034017 10.1074/jbc.REV118.002806 10.1016/j.ebiom.2019.11.024 10.3390/jcm10112391 10.1155/2020/8216541 10.1007/s13105-020-00730-8 10.1001/jama.2013.281053 10.1186/s12935-015-0185-1 10.1586/erm.10.11 10.1007/s13277-016-5065-3 10.1097/JCMA.0000000000000522 10.3892/mmr.2021.12224 10.1186/s12935-020-01608-x 10.3389/fonc.2021.749753 10.18632/oncotarget.18344 10.3109/00365513.2012.723135 10.3390/cells8111455 10.1016/j.biopha.2018.05.123 10.2147/CMAR.S207801 10.1002/pmic.201700169 10.1016/j.eururo.2011.01.004 10.1158/0008-5472.CAN-06-4511 10.18632/oncotarget.2484 10.1016/j.tcb.2017.11.008 10.1093/nar/gks1172 10.1016/j.jmoldx.2012.03.004 10.1038/s41467-020-19664-2 10.3892/or.2021.8062 10.1016/j.chest.2020.03.010 10.3390/ijms19123742 10.1038/nsmb.2125 10.1038/s41419-019-1705-z 10.1371/journal.pone.0276204 10.3390/cancers12113086 10.1038/nprot.2008.73 10.1016/j.biopha.2020.111158 10.1016/j.lfs.2022.120325 10.1016/j.omtn.2020.10.030 10.1136/gut.2008.156448 10.1016/j.yexcr.2021.112547 10.7150/jca.46343 10.1097/MPA.0b013e3182550d9d 10.3748/wjg.v25.i2.190 10.7754/Clin.Lab.2021.201130 10.1016/j.ijbiomac.2022.09.209 10.1016/j.ejca.2007.03.021 10.1245/s10434-010-0985-4 10.2217/bmm-2019-0534 10.1093/nar/gku394 10.1093/nar/gkac963 10.1080/15384047.2018.1538612 10.1016/j.bbrc.2018.12.090 10.1093/nar/gkw116 10.1016/j.biopha.2019.108695 10.7717/peerj.7946 10.1186/s12935-019-1052-2 10.1158/0008-5472.CAN-11-1021 10.1038/s41598-018-34604-3 10.3390/ijms221910317 10.3390/cells8020083 10.1007/s10151-018-1820-3 10.3390/cells8091015 10.1016/j.lfs.2022.120675 10.18632/oncotarget.13840 10.1186/s12885-019-5636-y 10.1007/s11033-020-05334-5 10.1093/nar/gkz757 10.3390/ijms232012541 10.1089/cbr.2019.3310 10.1002/jcb.27117 10.1186/s11658-019-0188-3 10.1016/j.biopha.2017.03.064 10.1016/j.cell.2018.01.011 10.1155/2020/8881687 10.1186/s12929-014-0095-x 10.7150/jca.24918 10.1080/07357907.2020.1752227 |
ContentType | Journal Article |
Copyright | 2023 Copyright © 2023. Published by Elsevier GmbH. |
Copyright_xml | – notice: 2023 – notice: Copyright © 2023. Published by Elsevier GmbH. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.prp.2023.154570 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1618-0631 |
ExternalDocumentID | 37244051 10_1016_j_prp_2023_154570 S0344033823002704 |
Genre | Journal Article |
GroupedDBID | --- --K --M .55 .GJ .~1 0R~ 123 1B1 1~. 1~5 29O 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 7X7 88E 88I 8AF 8FE 8FH 8FI 8FJ 8G5 8P~ 8R4 8R5 9JM AACTN AAEDT AAEDW AAIKJ AAKOC AAKPP AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO ABBQC ABFNM ABGSF ABLJU ABMAC ABMZM ABUDA ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACGOD ACPRK ACRLP ACRPL ADBBV ADEZE ADKUU ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AFJKZ AFKRA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJRQY AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BCR BCU BEC BENPR BHPHI BKOJK BLC BLXMC BNPGV BPHCQ BVXVI CAG CCPQU COF CS3 DU5 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IHE J1W K-O KOM L7B LK8 M1P M2O M2P M2Q M41 M7P MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PADUT PC. PEA PHGZT PQQKQ PRG PROAC PSQYO Q2X Q38 R2- RIG ROL RPZ S0X SDF SDG SES SEW SJFOW SSH SSZ T5I T5J T5K UDS UKHRP X7M YCJ ZGI ZXP ~G- AABNK AAYWO AAYXX ACIEU ACVFH ADCNI AEUPX AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP CITATION PHGZM SSU 3V. AFKWA AJOXV AMFUW NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c353t-5ad999ba44ef9eb0c3e308394b4176c7a678980d199f0900b2e05dd5bd2b46033 |
IEDL.DBID | .~1 |
ISSN | 0344-0338 1618-0631 |
IngestDate | Tue Aug 05 09:55:11 EDT 2025 Wed Feb 19 02:23:52 EST 2025 Tue Jul 01 02:16:26 EDT 2025 Thu Apr 24 23:08:44 EDT 2025 Sun Apr 06 06:53:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | lncRNA miRDB PT Colorectal cancer IBD LNM in silico ncRNAs Ct TNM UTR AJCC PLR Prognositic molecular biomarkers AKT1 KEGG cDNA HSP90 Hgb GO BCL9 NNT-AS1 NCI hsa SPs PPVs SNs NPVs Hsa-miR-485–5p LncRNA NNT-AS1 |
Language | English |
License | Copyright © 2023. Published by Elsevier GmbH. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c353t-5ad999ba44ef9eb0c3e308394b4176c7a678980d199f0900b2e05dd5bd2b46033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 37244051 |
PQID | 2820027908 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2820027908 pubmed_primary_37244051 crossref_primary_10_1016_j_prp_2023_154570 crossref_citationtrail_10_1016_j_prp_2023_154570 elsevier_sciencedirect_doi_10_1016_j_prp_2023_154570 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2023 2023-07-00 2023-Jul 20230701 |
PublicationDateYYYYMMDD | 2023-07-01 |
PublicationDate_xml | – month: 07 year: 2023 text: July 2023 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Pathology, research and practice |
PublicationTitleAlternate | Pathol Res Pract |
PublicationYear | 2023 |
Publisher | Elsevier GmbH |
Publisher_xml | – name: Elsevier GmbH |
References | Choo (bib33) 2014; 21 Zhao (bib38) 2019; 10 Yerukala Sathipati, Ho (bib94) 2018; 8 Li (bib27) 2019; 20 Yan, Wang, Qin (bib69) 2019; 509 Jing, Mo (bib77) 2016; 20 Zhang (bib98) 2020; 11 Lin (bib12) 2018; 19 Birbo (bib47) 2021; 22 El-Mesallamy (bib88) 2013; 42 Zhang (bib86) 2019; 7 Bi (bib30) 2019; 50 Samsonov (bib92) 2016; 37 Zhou (bib4) 2022; 21 Wang (bib29) 2019; 19 Laufs, Peters, Schultz (bib57) 2022; 17 Duffy (bib8) 2007; 43 Kim, Kim, Park (bib5) 2019; 25 Onyoh (bib10) 2019; 21 Nagaraju (bib87) 2014; 5 Xiao (bib37) 2019; 24 Genest, Wickner, Doyle (bib45) 2019; 294 Kopp, Mendell (bib11) 2018; 172 Łukaszewicz-Zając, Mroczko (bib7) 2021; 10 Abd El Fattah (bib43) 2022 El-Sheikh (bib28) 2022 Li (bib63) 2014; 42 Al-Noshokaty (bib22) 2022; 303 Ghafar (bib3) 2020; 47 Jafari (bib48) 2020; 38 Kanehisa (bib56) 2023; 51 Xu (bib18) 2020; 2020 Cheng (bib83) 2021; 402 Abbastabar (bib17) 2018; 17 Jiang (bib84) 2018; 119 McAnena (bib93) 2019; 19 Wang (bib73) 2017; 8 Zhong (bib14) 2018; 23 Wang (bib26) 2020 Huang (bib71) 2020; 24 Wu (bib97) 2021; 84 Wang (bib21) 2017; 8 Mahmoud (bib41) 2021; 11 Lou (bib79) 2016; 7 Gilad (bib91) 2012; 14 Pan (bib24) 2020; 34 Liu (bib36) 2019; 18 Chi (bib67) 2019; 8 Jiang (bib95) 2019; 215 Ferracin, Veronese, Negrini (bib75) 2010; 10 Liu (bib49) 2020; 76 Cui, Li (bib82) 2021; 45 Zheng (bib16) 2019; 112 Yin (bib19) 2021; 24 Wang, Ji (bib51) 2020; 158 Liu (bib25) 2020; 20 Tsutsumi (bib34) 2011; 18 Shen, Jiang (bib72) 2018; 105 Youssef (bib90) 2011; 59 Pinel (bib35) 2019; 8 Hammad (bib62) 2022; 23 Xu (bib13) 2020; 20 Kogo (bib66) 2011; 71 Wu (bib81) 2017; 90 Sur (bib31) 2019; 8 He (bib78) 2014; 9 Lin, Yang (bib70) 2018; 28 Niu (bib32) 2021; 23 Sun (bib6) 2019; 19 Chen, Wang (bib64) 2020; 48 Liu (bib76) 2021; 36 El-Mesallamy (bib89) 2012; 72 Xing (bib20) 2021; 134 Rizk (bib42) 2022 Wu (bib55) 2021; 2 Sung (bib2) 2021; 71 Seal (bib59) 2023; 51 Hu (bib39) 2018; 9 Wang (bib40) 2019; 23 Edge, Compton (bib53) 2010; 17 Subramanian, Lindgren (bib54) 2005; 34 Zhou, Duan (bib23) 2020; 12 Association, World Medical (bib52) 2013; 310 Pick (bib85) 2007; 67 Schmittgen, ivak KJ (bib60) 2008; 3 Graser (bib9) 2009; 58 Lim, Lim (bib1) 2018; 18 Huang (bib44) 2019; 11 Wang (bib50) 2017; 8 Reddy (bib74) 2015; 15 Yin (bib96) 2021; 24 Pan (bib80) 2020; 14 Biebl, Buchner (bib46) 2019; 11 Simion (bib15) 2020; 11 Ludwig (bib58) 2016; 44 Rosenbloom (bib65) 2012; 41 Kang (bib61) 2021; 67 Nikolaou (bib68) 2018; 22 Xu (10.1016/j.prp.2023.154570_bib13) 2020; 20 Liu (10.1016/j.prp.2023.154570_bib25) 2020; 20 Zhang (10.1016/j.prp.2023.154570_bib86) 2019; 7 Association (10.1016/j.prp.2023.154570_bib52) 2013; 310 Sur (10.1016/j.prp.2023.154570_bib31) 2019; 8 Jing (10.1016/j.prp.2023.154570_bib77) 2016; 20 Yerukala Sathipati (10.1016/j.prp.2023.154570_bib94) 2018; 8 Wang (10.1016/j.prp.2023.154570_bib51) 2020; 158 Kogo (10.1016/j.prp.2023.154570_bib66) 2011; 71 Huang (10.1016/j.prp.2023.154570_bib71) 2020; 24 Mahmoud (10.1016/j.prp.2023.154570_bib41) 2021; 11 Wang (10.1016/j.prp.2023.154570_bib40) 2019; 23 He (10.1016/j.prp.2023.154570_bib78) 2014; 9 Pan (10.1016/j.prp.2023.154570_bib80) 2020; 14 Hu (10.1016/j.prp.2023.154570_bib39) 2018; 9 Łukaszewicz-Zając (10.1016/j.prp.2023.154570_bib7) 2021; 10 Liu (10.1016/j.prp.2023.154570_bib76) 2021; 36 Yin (10.1016/j.prp.2023.154570_bib19) 2021; 24 Yin (10.1016/j.prp.2023.154570_bib96) 2021; 24 Ghafar (10.1016/j.prp.2023.154570_bib3) 2020; 47 Pinel (10.1016/j.prp.2023.154570_bib35) 2019; 8 Chen (10.1016/j.prp.2023.154570_bib64) 2020; 48 Al-Noshokaty (10.1016/j.prp.2023.154570_bib22) 2022; 303 Onyoh (10.1016/j.prp.2023.154570_bib10) 2019; 21 Xu (10.1016/j.prp.2023.154570_bib18) 2020; 2020 Zhao (10.1016/j.prp.2023.154570_bib38) 2019; 10 Choo (10.1016/j.prp.2023.154570_bib33) 2014; 21 Wu (10.1016/j.prp.2023.154570_bib81) 2017; 90 Kim (10.1016/j.prp.2023.154570_bib5) 2019; 25 Edge (10.1016/j.prp.2023.154570_bib53) 2010; 17 Gilad (10.1016/j.prp.2023.154570_bib91) 2012; 14 Nagaraju (10.1016/j.prp.2023.154570_bib87) 2014; 5 Xiao (10.1016/j.prp.2023.154570_bib37) 2019; 24 Sung (10.1016/j.prp.2023.154570_bib2) 2021; 71 Samsonov (10.1016/j.prp.2023.154570_bib92) 2016; 37 Rosenbloom (10.1016/j.prp.2023.154570_bib65) 2012; 41 Reddy (10.1016/j.prp.2023.154570_bib74) 2015; 15 Ferracin (10.1016/j.prp.2023.154570_bib75) 2010; 10 El-Sheikh (10.1016/j.prp.2023.154570_bib28) 2022 Li (10.1016/j.prp.2023.154570_bib27) 2019; 20 Niu (10.1016/j.prp.2023.154570_bib32) 2021; 23 Wang (10.1016/j.prp.2023.154570_bib50) 2017; 8 Li (10.1016/j.prp.2023.154570_bib63) 2014; 42 Nikolaou (10.1016/j.prp.2023.154570_bib68) 2018; 22 Lim (10.1016/j.prp.2023.154570_bib1) 2018; 18 Lin (10.1016/j.prp.2023.154570_bib12) 2018; 19 Wang (10.1016/j.prp.2023.154570_bib26) 2020 Kang (10.1016/j.prp.2023.154570_bib61) 2021; 67 Seal (10.1016/j.prp.2023.154570_bib59) 2023; 51 Chi (10.1016/j.prp.2023.154570_bib67) 2019; 8 Wu (10.1016/j.prp.2023.154570_bib97) 2021; 84 Genest (10.1016/j.prp.2023.154570_bib45) 2019; 294 Cheng (10.1016/j.prp.2023.154570_bib83) 2021; 402 Zhang (10.1016/j.prp.2023.154570_bib98) 2020; 11 Graser (10.1016/j.prp.2023.154570_bib9) 2009; 58 Simion (10.1016/j.prp.2023.154570_bib15) 2020; 11 Schmittgen (10.1016/j.prp.2023.154570_bib60) 2008; 3 Abd El Fattah (10.1016/j.prp.2023.154570_bib43) 2022 Ludwig (10.1016/j.prp.2023.154570_bib58) 2016; 44 Liu (10.1016/j.prp.2023.154570_bib36) 2019; 18 El-Mesallamy (10.1016/j.prp.2023.154570_bib88) 2013; 42 Liu (10.1016/j.prp.2023.154570_bib49) 2020; 76 Yan (10.1016/j.prp.2023.154570_bib69) 2019; 509 Lou (10.1016/j.prp.2023.154570_bib79) 2016; 7 Birbo (10.1016/j.prp.2023.154570_bib47) 2021; 22 El-Mesallamy (10.1016/j.prp.2023.154570_bib89) 2012; 72 Zhou (10.1016/j.prp.2023.154570_bib23) 2020; 12 Wang (10.1016/j.prp.2023.154570_bib29) 2019; 19 Jiang (10.1016/j.prp.2023.154570_bib84) 2018; 119 Youssef (10.1016/j.prp.2023.154570_bib90) 2011; 59 Sun (10.1016/j.prp.2023.154570_bib6) 2019; 19 McAnena (10.1016/j.prp.2023.154570_bib93) 2019; 19 Huang (10.1016/j.prp.2023.154570_bib44) 2019; 11 Hammad (10.1016/j.prp.2023.154570_bib62) 2022; 23 Lin (10.1016/j.prp.2023.154570_bib70) 2018; 28 Zhong (10.1016/j.prp.2023.154570_bib14) 2018; 23 Pan (10.1016/j.prp.2023.154570_bib24) 2020; 34 Kopp (10.1016/j.prp.2023.154570_bib11) 2018; 172 Kanehisa (10.1016/j.prp.2023.154570_bib56) 2023; 51 Pick (10.1016/j.prp.2023.154570_bib85) 2007; 67 Xing (10.1016/j.prp.2023.154570_bib20) 2021; 134 Subramanian (10.1016/j.prp.2023.154570_bib54) 2005; 34 Tsutsumi (10.1016/j.prp.2023.154570_bib34) 2011; 18 Abbastabar (10.1016/j.prp.2023.154570_bib17) 2018; 17 Laufs (10.1016/j.prp.2023.154570_bib57) 2022; 17 Duffy (10.1016/j.prp.2023.154570_bib8) 2007; 43 Wu (10.1016/j.prp.2023.154570_bib55) 2021; 2 Jafari (10.1016/j.prp.2023.154570_bib48) 2020; 38 Shen (10.1016/j.prp.2023.154570_bib72) 2018; 105 Wang (10.1016/j.prp.2023.154570_bib73) 2017; 8 Rizk (10.1016/j.prp.2023.154570_bib42) 2022 Bi (10.1016/j.prp.2023.154570_bib30) 2019; 50 Wang (10.1016/j.prp.2023.154570_bib21) 2017; 8 Zheng (10.1016/j.prp.2023.154570_bib16) 2019; 112 Cui (10.1016/j.prp.2023.154570_bib82) 2021; 45 Jiang (10.1016/j.prp.2023.154570_bib95) 2019; 215 Biebl (10.1016/j.prp.2023.154570_bib46) 2019; 11 Zhou (10.1016/j.prp.2023.154570_bib4) 2022; 21 |
References_xml | – volume: 72 start-page: 602 year: 2012 end-page: 607 ident: bib89 article-title: Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients publication-title: Scand. J. Clin. Lab. Investig. – volume: 76 start-page: 279 year: 2020 end-page: 290 ident: bib49 article-title: miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway publication-title: J. Physiol. Biochem. – volume: 34 start-page: 267 year: 2005 end-page: 273 ident: bib54 article-title: et al.(2003) publication-title: Nat. Genet – volume: 21 start-page: 36 year: 2019 ident: bib10 article-title: The rise of colorectal cancer in Asia: epidemiology, screening, and management publication-title: Curr. Gastroenterol. Rep. – volume: 119 start-page: 8623 year: 2018 end-page: 8635 ident: bib84 article-title: Epigallocatechin‐3–gallate inhibited cancer stem cell–like properties by targeting hsa‐mir‐485–5p/RXRα in lung cancer publication-title: J. Cell. Biochem. – volume: 11 start-page: a034017 year: 2019 ident: bib46 article-title: Structure, function, and regulation of the Hsp90 machinery publication-title: Cold Spring Harb. Perspect. Biol. – volume: 3 start-page: 1101 year: 2008 end-page: 1108 ident: bib60 article-title: Analyzing real-time PC'R data hy the comparative (2 (" I′) method: J 1 publication-title: Nat. Protoc. – volume: 20 start-page: 1 year: 2020 end-page: 12 ident: bib25 article-title: LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis publication-title: Cancer Cell Int. – volume: 17 year: 2022 ident: bib57 article-title: Data platforms for open life sciences–a systematic analysis of management instruments publication-title: Plos One – volume: 10 start-page: 1 year: 2019 end-page: 21 ident: bib38 article-title: miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer publication-title: Cell death Dis. – volume: 20 start-page: 413 year: 2019 end-page: 422 ident: bib27 article-title: Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a publication-title: Cancer Biol. Ther. – volume: 172 start-page: 393 year: 2018 end-page: 407 ident: bib11 article-title: Functional classification and experimental dissection of long noncoding RNAs publication-title: Cell – volume: 11 start-page: 6135 year: 2020 ident: bib15 article-title: A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus publication-title: Nat. Commun. – volume: 20 start-page: 536 year: 2020 ident: bib13 article-title: LncRNA SNHG3, a potential oncogene in human cancers publication-title: Cancer Cell Int. – volume: 105 start-page: 176 year: 2018 end-page: 181 ident: bib72 article-title: LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression publication-title: Biomed. Pharmacother. – volume: 34 start-page: 795 year: 2020 end-page: 805 ident: bib24 article-title: Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression publication-title: J. Biol. Regul. Homeost. Agents – volume: 45 start-page: 111 year: 2021 ident: bib82 article-title: RHPN1–AS1 promotes ovarian carcinogenesis by sponging miR‑485–5p and releasing TPX2 mRNA publication-title: Oncol. Rep. – volume: 67 start-page: 2932 year: 2007 end-page: 2937 ident: bib85 article-title: High HSP90 expression is associated with decreased survival in breast cancer publication-title: Cancer Res. – volume: 8 start-page: 1 year: 2018 end-page: 11 ident: bib94 article-title: Identifying a miRNA signature for predicting the stage of breast cancer publication-title: Sci. Rep. – volume: 17 start-page: 1471 year: 2010 end-page: 1474 ident: bib53 article-title: The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann. Surg. Oncol. – volume: 67 year: 2021 ident: bib61 article-title: Compare the diagnostic and prognostic value of MLR, NLR and PLR in CRC Patients publication-title: Clin. Lab. – volume: 23 start-page: 42 year: 2021 end-page: 54 ident: bib32 article-title: Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer publication-title: Mol. Ther. - Nucleic Acids – volume: 18 start-page: 1153 year: 2011 end-page: 1158 ident: bib34 article-title: Recognition of the pre-miRNA structure by drosophila dicer-1 publication-title: Nat. Struct. Mol. Biol. – volume: 24 start-page: 1 year: 2019 end-page: 13 ident: bib37 article-title: MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2 publication-title: Cell. Mol. Biol. Lett. – volume: 44 start-page: 3865 year: 2016 end-page: 3877 ident: bib58 article-title: Distribution of miRNA expression across human tissues publication-title: Nucleic Acids Res. – volume: 14 start-page: 239 year: 2020 end-page: 248 ident: bib80 article-title: MiR-485-5p as a potential biomarker and tumor suppressor in human colorectal cancer publication-title: Biomark. Med. – volume: 19 start-page: 327 year: 2019 ident: bib29 article-title: Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma publication-title: Cancer Cell Int. – volume: 15 start-page: 1 year: 2015 end-page: 6 ident: bib74 article-title: MicroRNA (miRNA) in cancer publication-title: Cancer Cell Int. – volume: 59 start-page: 721 year: 2011 end-page: 730 ident: bib90 article-title: Accurate molecular classification of kidney cancer subtypes using microRNA signature publication-title: Eur. Urol. – volume: 8 start-page: 83 year: 2019 ident: bib35 article-title: Substantial dysregulation of miRNA passenger strands underlies the vascular response to injury publication-title: Cells – volume: 36 start-page: 737 year: 2021 end-page: 752 ident: bib76 article-title: Knockdown of circAPLP2 inhibits progression of colorectal cancer by regulating miR-485-5p/FOXK1 axis publication-title: Cancer Biotherapy Radiopharm. – volume: 8 start-page: 3441 year: 2017 ident: bib50 article-title: Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo publication-title: Oncotarget – volume: 112 year: 2019 ident: bib16 article-title: LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma publication-title: Biomed. Pharmacother. – volume: 23 start-page: 776 year: 2018 end-page: 781 ident: bib14 article-title: LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines publication-title: J. B. U. .: Off. J. Balk. Union Oncol. – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: bib2 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA: a Cancer J. Clin. – volume: 24 start-page: 238 year: 2020 end-page: 248 ident: bib71 article-title: LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis publication-title: Eur. Rev. Med Pharm. Sci. – volume: 37 start-page: 12011 year: 2016 end-page: 12021 ident: bib92 article-title: Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer publication-title: Tumor Biol. – volume: 24 start-page: 585 year: 2021 ident: bib96 article-title: Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer publication-title: Mol. Med. Rep. – volume: 2 year: 2021 ident: bib55 article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data publication-title: Innovation – volume: 84 start-page: 491 year: 2021 end-page: 497 ident: bib97 article-title: Diagnostic significance of circulating miR-485-5p in patients with lupus nephritis and its predictive value evaluation for the clinical outcomes publication-title: J. Chin. Med. Assoc. – volume: 11 year: 2021 ident: bib41 article-title: Competitive endogenous role of the LINC00511/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis publication-title: Front. Oncol. – volume: 8 start-page: 1015 year: 2019 ident: bib67 article-title: Long non-coding RNA in the pathogenesis of cancers publication-title: Cells – volume: 8 start-page: 64638 year: 2017 ident: bib21 article-title: LncRNA UCA1 in anti-cancer drug resistance publication-title: Oncotarget – volume: 48 start-page: D127 year: 2020 end-page: D131 ident: bib64 article-title: miRDB: an online database for prediction of functional microRNA targets publication-title: Nucleic Acids Res. – volume: 25 start-page: 190 year: 2019 end-page: 204 ident: bib5 article-title: Adverse events related to colonoscopy: global trends and future challenges publication-title: World J. Gastroenterol. – volume: 22 start-page: 481 year: 2018 end-page: 498 ident: bib68 article-title: Systematic review of blood diagnostic markers in colorectal cancer publication-title: Tech. Coloproctology – volume: 51 start-page: D1003 year: 2023 end-page: D1009 ident: bib59 article-title: Genenames. org: the HGNC resources in 2023 publication-title: Nucleic Acids Res. – volume: 9 year: 2014 ident: bib78 article-title: miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk publication-title: PloS One – volume: 2020 start-page: 8881687 year: 2020 ident: bib18 article-title: Autophagy-associated lncRNAs: promising targets for neurological disease diagnosis and therapy publication-title: Neural Plast. – volume: 18 start-page: 1212 year: 2019 end-page: 1220 ident: bib36 article-title: Long non‑coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA‑16 publication-title: Exp. Ther. Med – volume: 58 start-page: 241 year: 2009 end-page: 248 ident: bib9 article-title: Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population publication-title: Gut – volume: 19 start-page: 3742 year: 2018 ident: bib12 article-title: Long non-coding RNAs as mediators of tumor microenvironment and liver cancer cell communication publication-title: Int. J. Mol. Sci. – volume: 8 start-page: 1455 year: 2019 ident: bib31 article-title: miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression publication-title: Cells – volume: 38 start-page: 310 year: 2020 end-page: 328 ident: bib48 article-title: HSP90 and Co-chaperones: impact on tumor progression and prospects for molecular-targeted cancer therapy publication-title: Cancer Investig. – volume: 11 start-page: 7739 year: 2019 end-page: 7749 ident: bib44 article-title: Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma publication-title: Cancer Manag. Res. – volume: 90 start-page: 303 year: 2017 end-page: 310 ident: bib81 article-title: MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7 publication-title: Biomed. Pharmacother. – volume: 42 start-page: 149 year: 2013 end-page: 154 ident: bib88 article-title: Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis publication-title: Pancreas – volume: 134 year: 2021 ident: bib20 article-title: Role of lncRNA LUCAT1 in cancer publication-title: Biomed. Pharmacother. – volume: 21 start-page: 86 year: 2022 ident: bib4 article-title: Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer publication-title: Mol. Cancer – volume: 509 start-page: 441 year: 2019 end-page: 447 ident: bib69 article-title: A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC publication-title: Biochem. Biophys. Res. Commun. – volume: 19 start-page: 450 year: 2019 ident: bib6 article-title: The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer publication-title: BMC Cancer – volume: 7 year: 2019 ident: bib86 article-title: High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer publication-title: PeerJ – volume: 10 start-page: 297 year: 2010 end-page: 308 ident: bib75 article-title: Micromarkers: miRNAs in cancer diagnosis and prognosis publication-title: Expert Rev. Mol. Diagn. – volume: 14 start-page: 510 year: 2012 end-page: 517 ident: bib91 article-title: Classification of the four main types of lung cancer using a microRNA-based diagnostic assay publication-title: J. Mol. Diagn. – volume: 303 year: 2022 ident: bib22 article-title: Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis publication-title: Life Sci. – volume: 9 start-page: 2603 year: 2018 end-page: 2611 ident: bib39 article-title: microRNA-485-5p Functions as a tumor suppressor in colorectal cancer cells by targeting CD147 publication-title: J. Cancer – volume: 41 start-page: D56 year: 2012 end-page: D63 ident: bib65 article-title: ENCODE data in the UCSC genome browser: year 5 update publication-title: Nucleic Acids Res. – volume: 20 start-page: 1516 year: 2016 end-page: 1520 ident: bib77 article-title: Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer publication-title: Eur. Rev. Med Pharm. Sci. – volume: 7 year: 2016 ident: bib79 article-title: MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression publication-title: Cell Death Dis. – volume: 43 start-page: 1348 year: 2007 end-page: 1360 ident: bib8 article-title: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use publication-title: Eur. J. Cancer – volume: 42 start-page: W240 year: 2014 end-page: W245 ident: bib63 article-title: POSA: a user-driven, interactive multiple protein structure alignment server publication-title: Nucleic Acids Res. – volume: 18 start-page: 1700169 year: 2018 ident: bib1 article-title: Proteome heterogeneity in colorectal cancer publication-title: Proteomics – volume: 10 start-page: 2391 year: 2021 ident: bib7 article-title: Circulating biomarkers of colorectal cancer (CRC)—their utility in diagnosis and prognosis publication-title: J. Clin. Med. – year: 2022 ident: bib42 article-title: Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players publication-title: Life Sci. – volume: 21 start-page: 95 year: 2014 ident: bib33 article-title: MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells publication-title: J. Biomed. Sci. – volume: 17 start-page: 900 year: 2018 end-page: 913 ident: bib17 article-title: lncRNA involvement in hepatocellular carcinoma metastasis and prognosis publication-title: Excli J. – volume: 28 start-page: 287 year: 2018 end-page: 301 ident: bib70 article-title: Long noncoding RNA in cancer: wiring signaling circuitry publication-title: Trends Cell Biol. – year: 2022 ident: bib43 article-title: Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond publication-title: Int. J. Biol. Macromol. – volume: 11 start-page: 5890 year: 2020 end-page: 5899 ident: bib98 article-title: Diagnostic, clinicopathologic, therapeutic and prognostic value of plasma heat shock protein 90 levels in patients with advanced gastrointestinal carcinoma publication-title: J. Cancer – year: 2022 ident: bib28 article-title: Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association publication-title: Pathol. - Res. Pract. – volume: 294 start-page: 2109 year: 2019 end-page: 2120 ident: bib45 article-title: Hsp90 and Hsp70 chaperones: collaborators in protein remodeling publication-title: J. Biol. Chem. – volume: 71 start-page: 6320 year: 2011 end-page: 6326 ident: bib66 article-title: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers publication-title: Cancer Res. – volume: 310 start-page: 2191 year: 2013 end-page: 2194 ident: bib52 article-title: ssociation declaration of helsinki: ethical principles for medical research involving human subjects publication-title: JAMA – volume: 24 start-page: 1 year: 2021 end-page: 11 ident: bib19 article-title: Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer publication-title: Mol. Med. Rep. – year: 2020 ident: bib26 article-title: Overexpression of NNT-AS1 activates TGF-β signaling to decrease tumor CD4 lymphocyte infiltration in hepatocellular carcinoma publication-title: BioMed. Res. Int. 2020 – volume: 8 start-page: 3441 year: 2017 end-page: 3453 ident: bib73 article-title: Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo publication-title: Oncotarget – volume: 402 year: 2021 ident: bib83 article-title: A HIF1A/miR-485–5p/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia publication-title: Exp. Cell Res. – volume: 23 start-page: 12541 year: 2022 ident: bib62 article-title: Cytotoxic T cell expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) in viral hepatitis C-mediated hepatocellular carcinoma publication-title: Int. J. Mol. Sci. – volume: 5 start-page: 9980 year: 2014 end-page: 9991 ident: bib87 article-title: HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy publication-title: Oncotarget – volume: 51 start-page: D587 year: 2023 end-page: D592 ident: bib56 article-title: KEGG for taxonomy-based analysis of pathways and genomes publication-title: Nucleic Acids Res. – volume: 215 year: 2019 ident: bib95 article-title: Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis publication-title: Pathol. -Res. Pract. – volume: 158 start-page: S12 year: 2020 end-page: S20 ident: bib51 article-title: Sample size estimation in clinical research: from randomized controlled trials to observational studies publication-title: Chest – volume: 19 start-page: 1 year: 2019 end-page: 10 ident: bib93 article-title: Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer publication-title: BMC Cancer – volume: 23 start-page: 4842 year: 2019 end-page: 4849 ident: bib40 article-title: MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4 publication-title: Eur. Rev. Med Pharm. Sci. – volume: 47 start-page: 2509 year: 2020 end-page: 2519 ident: bib3 article-title: Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer publication-title: Mol. Biol. Rep. – volume: 22 start-page: 10317 year: 2021 ident: bib47 article-title: Role of HSP90 in cancer publication-title: Int. J. Mol. Sci. – volume: 12 start-page: 3086 year: 2020 ident: bib23 article-title: The role of long non-coding RNA NNT-AS1 in neoplastic disease publication-title: Cancers – volume: 50 start-page: 408 year: 2019 end-page: 420 ident: bib30 article-title: LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis publication-title: EBioMedicine – volume: 51 start-page: D1003 year: 2023 ident: 10.1016/j.prp.2023.154570_bib59 article-title: Genenames. org: the HGNC resources in 2023 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac888 – volume: 21 start-page: 36 year: 2019 ident: 10.1016/j.prp.2023.154570_bib10 article-title: The rise of colorectal cancer in Asia: epidemiology, screening, and management publication-title: Curr. Gastroenterol. Rep. doi: 10.1007/s11894-019-0703-8 – volume: 21 start-page: 86 year: 2022 ident: 10.1016/j.prp.2023.154570_bib4 article-title: Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer publication-title: Mol. Cancer doi: 10.1186/s12943-022-01556-2 – volume: 19 start-page: 450 year: 2019 ident: 10.1016/j.prp.2023.154570_bib6 article-title: The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer publication-title: BMC Cancer doi: 10.1186/s12885-019-5663-8 – year: 2022 ident: 10.1016/j.prp.2023.154570_bib28 article-title: Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association publication-title: Pathol. - Res. Pract. doi: 10.1016/j.prp.2022.154183 – volume: 20 start-page: 1516 year: 2016 ident: 10.1016/j.prp.2023.154570_bib77 article-title: Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer publication-title: Eur. Rev. Med Pharm. Sci. – volume: 7 year: 2016 ident: 10.1016/j.prp.2023.154570_bib79 article-title: MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression publication-title: Cell Death Dis. doi: 10.1038/cddis.2016.27 – volume: 11 start-page: a034017 year: 2019 ident: 10.1016/j.prp.2023.154570_bib46 article-title: Structure, function, and regulation of the Hsp90 machinery publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a034017 – volume: 294 start-page: 2109 year: 2019 ident: 10.1016/j.prp.2023.154570_bib45 article-title: Hsp90 and Hsp70 chaperones: collaborators in protein remodeling publication-title: J. Biol. Chem. doi: 10.1074/jbc.REV118.002806 – volume: 50 start-page: 408 year: 2019 ident: 10.1016/j.prp.2023.154570_bib30 article-title: LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.11.024 – volume: 10 start-page: 2391 year: 2021 ident: 10.1016/j.prp.2023.154570_bib7 article-title: Circulating biomarkers of colorectal cancer (CRC)—their utility in diagnosis and prognosis publication-title: J. Clin. Med. doi: 10.3390/jcm10112391 – volume: 24 start-page: 238 year: 2020 ident: 10.1016/j.prp.2023.154570_bib71 article-title: LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis publication-title: Eur. Rev. Med Pharm. Sci. – year: 2020 ident: 10.1016/j.prp.2023.154570_bib26 article-title: Overexpression of NNT-AS1 activates TGF-β signaling to decrease tumor CD4 lymphocyte infiltration in hepatocellular carcinoma publication-title: BioMed. Res. Int. 2020 doi: 10.1155/2020/8216541 – volume: 76 start-page: 279 year: 2020 ident: 10.1016/j.prp.2023.154570_bib49 article-title: miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway publication-title: J. Physiol. Biochem. doi: 10.1007/s13105-020-00730-8 – volume: 310 start-page: 2191 year: 2013 ident: 10.1016/j.prp.2023.154570_bib52 article-title: ssociation declaration of helsinki: ethical principles for medical research involving human subjects publication-title: JAMA doi: 10.1001/jama.2013.281053 – volume: 15 start-page: 1 year: 2015 ident: 10.1016/j.prp.2023.154570_bib74 article-title: MicroRNA (miRNA) in cancer publication-title: Cancer Cell Int. doi: 10.1186/s12935-015-0185-1 – volume: 10 start-page: 297 year: 2010 ident: 10.1016/j.prp.2023.154570_bib75 article-title: Micromarkers: miRNAs in cancer diagnosis and prognosis publication-title: Expert Rev. Mol. Diagn. doi: 10.1586/erm.10.11 – volume: 37 start-page: 12011 year: 2016 ident: 10.1016/j.prp.2023.154570_bib92 article-title: Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer publication-title: Tumor Biol. doi: 10.1007/s13277-016-5065-3 – volume: 84 start-page: 491 year: 2021 ident: 10.1016/j.prp.2023.154570_bib97 article-title: Diagnostic significance of circulating miR-485-5p in patients with lupus nephritis and its predictive value evaluation for the clinical outcomes publication-title: J. Chin. Med. Assoc. doi: 10.1097/JCMA.0000000000000522 – volume: 24 start-page: 1 year: 2021 ident: 10.1016/j.prp.2023.154570_bib19 article-title: Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2021.12224 – volume: 20 start-page: 536 year: 2020 ident: 10.1016/j.prp.2023.154570_bib13 article-title: LncRNA SNHG3, a potential oncogene in human cancers publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-01608-x – volume: 11 year: 2021 ident: 10.1016/j.prp.2023.154570_bib41 article-title: Competitive endogenous role of the LINC00511/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis publication-title: Front. Oncol. doi: 10.3389/fonc.2021.749753 – volume: 8 start-page: 64638 year: 2017 ident: 10.1016/j.prp.2023.154570_bib21 article-title: LncRNA UCA1 in anti-cancer drug resistance publication-title: Oncotarget doi: 10.18632/oncotarget.18344 – volume: 72 start-page: 602 year: 2012 ident: 10.1016/j.prp.2023.154570_bib89 article-title: Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients publication-title: Scand. J. Clin. Lab. Investig. doi: 10.3109/00365513.2012.723135 – volume: 8 start-page: 1455 year: 2019 ident: 10.1016/j.prp.2023.154570_bib31 article-title: miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression publication-title: Cells doi: 10.3390/cells8111455 – volume: 105 start-page: 176 year: 2018 ident: 10.1016/j.prp.2023.154570_bib72 article-title: LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.05.123 – volume: 11 start-page: 7739 year: 2019 ident: 10.1016/j.prp.2023.154570_bib44 article-title: Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S207801 – volume: 18 start-page: 1700169 year: 2018 ident: 10.1016/j.prp.2023.154570_bib1 article-title: Proteome heterogeneity in colorectal cancer publication-title: Proteomics doi: 10.1002/pmic.201700169 – volume: 59 start-page: 721 year: 2011 ident: 10.1016/j.prp.2023.154570_bib90 article-title: Accurate molecular classification of kidney cancer subtypes using microRNA signature publication-title: Eur. Urol. doi: 10.1016/j.eururo.2011.01.004 – volume: 67 start-page: 2932 year: 2007 ident: 10.1016/j.prp.2023.154570_bib85 article-title: High HSP90 expression is associated with decreased survival in breast cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4511 – volume: 5 start-page: 9980 year: 2014 ident: 10.1016/j.prp.2023.154570_bib87 article-title: HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy publication-title: Oncotarget doi: 10.18632/oncotarget.2484 – volume: 24 start-page: 585 year: 2021 ident: 10.1016/j.prp.2023.154570_bib96 article-title: Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2021.12224 – volume: 28 start-page: 287 year: 2018 ident: 10.1016/j.prp.2023.154570_bib70 article-title: Long noncoding RNA in cancer: wiring signaling circuitry publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2017.11.008 – volume: 41 start-page: D56 year: 2012 ident: 10.1016/j.prp.2023.154570_bib65 article-title: ENCODE data in the UCSC genome browser: year 5 update publication-title: Nucleic Acids Res. doi: 10.1093/nar/gks1172 – volume: 17 start-page: 900 year: 2018 ident: 10.1016/j.prp.2023.154570_bib17 article-title: lncRNA involvement in hepatocellular carcinoma metastasis and prognosis publication-title: Excli J. – volume: 14 start-page: 510 year: 2012 ident: 10.1016/j.prp.2023.154570_bib91 article-title: Classification of the four main types of lung cancer using a microRNA-based diagnostic assay publication-title: J. Mol. Diagn. doi: 10.1016/j.jmoldx.2012.03.004 – volume: 11 start-page: 6135 year: 2020 ident: 10.1016/j.prp.2023.154570_bib15 article-title: A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus publication-title: Nat. Commun. doi: 10.1038/s41467-020-19664-2 – volume: 45 start-page: 111 year: 2021 ident: 10.1016/j.prp.2023.154570_bib82 article-title: RHPN1–AS1 promotes ovarian carcinogenesis by sponging miR‑485–5p and releasing TPX2 mRNA publication-title: Oncol. Rep. doi: 10.3892/or.2021.8062 – volume: 158 start-page: S12 year: 2020 ident: 10.1016/j.prp.2023.154570_bib51 article-title: Sample size estimation in clinical research: from randomized controlled trials to observational studies publication-title: Chest doi: 10.1016/j.chest.2020.03.010 – volume: 19 start-page: 3742 year: 2018 ident: 10.1016/j.prp.2023.154570_bib12 article-title: Long non-coding RNAs as mediators of tumor microenvironment and liver cancer cell communication publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19123742 – volume: 20 start-page: 1 year: 2020 ident: 10.1016/j.prp.2023.154570_bib25 article-title: LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis publication-title: Cancer Cell Int. – volume: 18 start-page: 1153 year: 2011 ident: 10.1016/j.prp.2023.154570_bib34 article-title: Recognition of the pre-miRNA structure by drosophila dicer-1 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb.2125 – volume: 10 start-page: 1 year: 2019 ident: 10.1016/j.prp.2023.154570_bib38 article-title: miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer publication-title: Cell death Dis. doi: 10.1038/s41419-019-1705-z – volume: 17 year: 2022 ident: 10.1016/j.prp.2023.154570_bib57 article-title: Data platforms for open life sciences–a systematic analysis of management instruments publication-title: Plos One doi: 10.1371/journal.pone.0276204 – volume: 215 year: 2019 ident: 10.1016/j.prp.2023.154570_bib95 article-title: Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis publication-title: Pathol. -Res. Pract. – volume: 12 start-page: 3086 year: 2020 ident: 10.1016/j.prp.2023.154570_bib23 article-title: The role of long non-coding RNA NNT-AS1 in neoplastic disease publication-title: Cancers doi: 10.3390/cancers12113086 – volume: 3 start-page: 1101 issue: 6 year: 2008 ident: 10.1016/j.prp.2023.154570_bib60 article-title: Analyzing real-time PC'R data hy the comparative (2 (" I′) method: J 1 publication-title: Nat. Protoc. doi: 10.1038/nprot.2008.73 – volume: 134 year: 2021 ident: 10.1016/j.prp.2023.154570_bib20 article-title: Role of lncRNA LUCAT1 in cancer publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.111158 – year: 2022 ident: 10.1016/j.prp.2023.154570_bib42 article-title: Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players publication-title: Life Sci. doi: 10.1016/j.lfs.2022.120325 – volume: 23 start-page: 42 year: 2021 ident: 10.1016/j.prp.2023.154570_bib32 article-title: Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer publication-title: Mol. Ther. - Nucleic Acids doi: 10.1016/j.omtn.2020.10.030 – volume: 58 start-page: 241 year: 2009 ident: 10.1016/j.prp.2023.154570_bib9 article-title: Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population publication-title: Gut doi: 10.1136/gut.2008.156448 – volume: 23 start-page: 776 year: 2018 ident: 10.1016/j.prp.2023.154570_bib14 article-title: LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines publication-title: J. B. U. .: Off. J. Balk. Union Oncol. – volume: 402 year: 2021 ident: 10.1016/j.prp.2023.154570_bib83 article-title: A HIF1A/miR-485–5p/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2021.112547 – volume: 11 start-page: 5890 year: 2020 ident: 10.1016/j.prp.2023.154570_bib98 article-title: Diagnostic, clinicopathologic, therapeutic and prognostic value of plasma heat shock protein 90 levels in patients with advanced gastrointestinal carcinoma publication-title: J. Cancer doi: 10.7150/jca.46343 – volume: 42 start-page: 149 year: 2013 ident: 10.1016/j.prp.2023.154570_bib88 article-title: Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis publication-title: Pancreas doi: 10.1097/MPA.0b013e3182550d9d – volume: 25 start-page: 190 year: 2019 ident: 10.1016/j.prp.2023.154570_bib5 article-title: Adverse events related to colonoscopy: global trends and future challenges publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v25.i2.190 – volume: 67 year: 2021 ident: 10.1016/j.prp.2023.154570_bib61 article-title: Compare the diagnostic and prognostic value of MLR, NLR and PLR in CRC Patients publication-title: Clin. Lab. doi: 10.7754/Clin.Lab.2021.201130 – year: 2022 ident: 10.1016/j.prp.2023.154570_bib43 article-title: Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2022.09.209 – volume: 43 start-page: 1348 year: 2007 ident: 10.1016/j.prp.2023.154570_bib8 article-title: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2007.03.021 – volume: 17 start-page: 1471 year: 2010 ident: 10.1016/j.prp.2023.154570_bib53 article-title: The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-010-0985-4 – volume: 14 start-page: 239 year: 2020 ident: 10.1016/j.prp.2023.154570_bib80 article-title: MiR-485-5p as a potential biomarker and tumor suppressor in human colorectal cancer publication-title: Biomark. Med. doi: 10.2217/bmm-2019-0534 – volume: 42 start-page: W240 year: 2014 ident: 10.1016/j.prp.2023.154570_bib63 article-title: POSA: a user-driven, interactive multiple protein structure alignment server publication-title: Nucleic Acids Res. doi: 10.1093/nar/gku394 – volume: 51 start-page: D587 year: 2023 ident: 10.1016/j.prp.2023.154570_bib56 article-title: KEGG for taxonomy-based analysis of pathways and genomes publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac963 – volume: 20 start-page: 413 year: 2019 ident: 10.1016/j.prp.2023.154570_bib27 article-title: Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2018.1538612 – volume: 509 start-page: 441 year: 2019 ident: 10.1016/j.prp.2023.154570_bib69 article-title: A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.12.090 – volume: 71 start-page: 209 year: 2021 ident: 10.1016/j.prp.2023.154570_bib2 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA: a Cancer J. Clin. – volume: 44 start-page: 3865 year: 2016 ident: 10.1016/j.prp.2023.154570_bib58 article-title: Distribution of miRNA expression across human tissues publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw116 – volume: 112 year: 2019 ident: 10.1016/j.prp.2023.154570_bib16 article-title: LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2019.108695 – volume: 7 year: 2019 ident: 10.1016/j.prp.2023.154570_bib86 article-title: High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer publication-title: PeerJ doi: 10.7717/peerj.7946 – volume: 19 start-page: 327 year: 2019 ident: 10.1016/j.prp.2023.154570_bib29 article-title: Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma publication-title: Cancer Cell Int. doi: 10.1186/s12935-019-1052-2 – volume: 71 start-page: 6320 year: 2011 ident: 10.1016/j.prp.2023.154570_bib66 article-title: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-1021 – volume: 8 start-page: 1 year: 2018 ident: 10.1016/j.prp.2023.154570_bib94 article-title: Identifying a miRNA signature for predicting the stage of breast cancer publication-title: Sci. Rep. doi: 10.1038/s41598-018-34604-3 – volume: 34 start-page: 795 year: 2020 ident: 10.1016/j.prp.2023.154570_bib24 article-title: Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression publication-title: J. Biol. Regul. Homeost. Agents – volume: 22 start-page: 10317 year: 2021 ident: 10.1016/j.prp.2023.154570_bib47 article-title: Role of HSP90 in cancer publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms221910317 – volume: 8 start-page: 83 year: 2019 ident: 10.1016/j.prp.2023.154570_bib35 article-title: Substantial dysregulation of miRNA passenger strands underlies the vascular response to injury publication-title: Cells doi: 10.3390/cells8020083 – volume: 22 start-page: 481 year: 2018 ident: 10.1016/j.prp.2023.154570_bib68 article-title: Systematic review of blood diagnostic markers in colorectal cancer publication-title: Tech. Coloproctology doi: 10.1007/s10151-018-1820-3 – volume: 2 year: 2021 ident: 10.1016/j.prp.2023.154570_bib55 article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data publication-title: Innovation – volume: 8 start-page: 1015 year: 2019 ident: 10.1016/j.prp.2023.154570_bib67 article-title: Long non-coding RNA in the pathogenesis of cancers publication-title: Cells doi: 10.3390/cells8091015 – volume: 303 year: 2022 ident: 10.1016/j.prp.2023.154570_bib22 article-title: Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis publication-title: Life Sci. doi: 10.1016/j.lfs.2022.120675 – volume: 9 year: 2014 ident: 10.1016/j.prp.2023.154570_bib78 article-title: miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk publication-title: PloS One – volume: 8 start-page: 3441 year: 2017 ident: 10.1016/j.prp.2023.154570_bib73 article-title: Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo publication-title: Oncotarget doi: 10.18632/oncotarget.13840 – volume: 18 start-page: 1212 year: 2019 ident: 10.1016/j.prp.2023.154570_bib36 article-title: Long non‑coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA‑16 publication-title: Exp. Ther. Med – volume: 23 start-page: 4842 year: 2019 ident: 10.1016/j.prp.2023.154570_bib40 article-title: MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4 publication-title: Eur. Rev. Med Pharm. Sci. – volume: 19 start-page: 1 year: 2019 ident: 10.1016/j.prp.2023.154570_bib93 article-title: Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer publication-title: BMC Cancer doi: 10.1186/s12885-019-5636-y – volume: 47 start-page: 2509 year: 2020 ident: 10.1016/j.prp.2023.154570_bib3 article-title: Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-020-05334-5 – volume: 48 start-page: D127 year: 2020 ident: 10.1016/j.prp.2023.154570_bib64 article-title: miRDB: an online database for prediction of functional microRNA targets publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkz757 – volume: 23 start-page: 12541 year: 2022 ident: 10.1016/j.prp.2023.154570_bib62 article-title: Cytotoxic T cell expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) in viral hepatitis C-mediated hepatocellular carcinoma publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms232012541 – volume: 36 start-page: 737 year: 2021 ident: 10.1016/j.prp.2023.154570_bib76 article-title: Knockdown of circAPLP2 inhibits progression of colorectal cancer by regulating miR-485-5p/FOXK1 axis publication-title: Cancer Biotherapy Radiopharm. doi: 10.1089/cbr.2019.3310 – volume: 34 start-page: 267 year: 2005 ident: 10.1016/j.prp.2023.154570_bib54 article-title: et al.(2003) publication-title: Nat. Genet – volume: 119 start-page: 8623 year: 2018 ident: 10.1016/j.prp.2023.154570_bib84 article-title: Epigallocatechin‐3–gallate inhibited cancer stem cell–like properties by targeting hsa‐mir‐485–5p/RXRα in lung cancer publication-title: J. Cell. Biochem. doi: 10.1002/jcb.27117 – volume: 24 start-page: 1 year: 2019 ident: 10.1016/j.prp.2023.154570_bib37 article-title: MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2 publication-title: Cell. Mol. Biol. Lett. doi: 10.1186/s11658-019-0188-3 – volume: 90 start-page: 303 year: 2017 ident: 10.1016/j.prp.2023.154570_bib81 article-title: MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.03.064 – volume: 172 start-page: 393 year: 2018 ident: 10.1016/j.prp.2023.154570_bib11 article-title: Functional classification and experimental dissection of long noncoding RNAs publication-title: Cell doi: 10.1016/j.cell.2018.01.011 – volume: 8 start-page: 3441 year: 2017 ident: 10.1016/j.prp.2023.154570_bib50 article-title: Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo publication-title: Oncotarget doi: 10.18632/oncotarget.13840 – volume: 2020 start-page: 8881687 year: 2020 ident: 10.1016/j.prp.2023.154570_bib18 article-title: Autophagy-associated lncRNAs: promising targets for neurological disease diagnosis and therapy publication-title: Neural Plast. doi: 10.1155/2020/8881687 – volume: 21 start-page: 95 year: 2014 ident: 10.1016/j.prp.2023.154570_bib33 article-title: MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells publication-title: J. Biomed. Sci. doi: 10.1186/s12929-014-0095-x – volume: 9 start-page: 2603 year: 2018 ident: 10.1016/j.prp.2023.154570_bib39 article-title: microRNA-485-5p Functions as a tumor suppressor in colorectal cancer cells by targeting CD147 publication-title: J. Cancer doi: 10.7150/jca.24918 – volume: 38 start-page: 310 year: 2020 ident: 10.1016/j.prp.2023.154570_bib48 article-title: HSP90 and Co-chaperones: impact on tumor progression and prospects for molecular-targeted cancer therapy publication-title: Cancer Investig. doi: 10.1080/07357907.2020.1752227 |
SSID | ssj0007041 |
Score | 2.5116246 |
Snippet | The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn’t... The oncogenic effects of long non-coding RNA (lncRNA) Nicotinamide Nucleotide Transhydrogenase-antisense RNA1 (NNT-AS1) role in colorectal cancer (CRC) hasn't... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 154570 |
SubjectTerms | Colorectal cancer Hsa-miR-485–5p HSP90 in silico LncRNA NNT-AS1 Prognositic molecular biomarkers |
Title | LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision |
URI | https://dx.doi.org/10.1016/j.prp.2023.154570 https://www.ncbi.nlm.nih.gov/pubmed/37244051 https://www.proquest.com/docview/2820027908 |
Volume | 247 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqIiEuiH_KT2UkTkgmTmxv1tyiFdXy06jabaXeIttxIGjJRptU4oR4B96AR-NJmHGSIiTogWMcO5l4Jp4v8cw3hDwHDyeMSRRzNrZMViJh2nl43RXye2FOuMR85-N8tjyTb8_V-R5ZTLkwGFY5rv3Dmh5W67ElGmczaus6WiNZHRe4j4XfVoETVMoUrfzl199hHnAiVM2Dzgx7TzubIcarDZSVicD_KwrrFf_dN_0LewYfdHSL3BzBI80G-W6TPd_cIdePx-3xu-TH-8at8ozm-SnL1nH0sTPsc71icq5-fvuu2mi5PtGcmi91R-uGdfUG7ICapqRTgiQFGULyJXVYtmMDSLRk_ZYGWuKwTNIPO1P6jqH7K-litaAD8241_vx7RTNo8S3tQ0AuHSQ62Y21fO6Rs6PXp4slG4swMCeU6JkyJWBIa6T0lfaWO-EFwDYtrYzTmUsNeDs952WsdcU15zbxXJWlsmVi5Qxm_D7Zb7aNf0goVxWgI6ddbC3gRCTqhwuIxOrUVPFsfkD4NP2FGxnKsVDGpphC0T4VoLECNVYMGjsgLy6HtAM9x1Wd5aTT4g8bK8B9XDXs2aT_At493FAxjd9edAV8rqLpaQ6iPxgM41IKkQJwgod89H83fUxu4NEQGPyE7Pe7C_8U4E9vD4N9H5Jr2Zt3y_wX0IgBMQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZWXQm4IP5Zfo3ECcmKE9ttzS2qWGXZNlq1XWlvlu04EFTSqOlKHHkH3oBH40kYJ04lJNgD1yROJp7JzOd45huE3kKEY1onglgTG8JLlhBpHXzuwvN7-Zpw7uudF_k4u-Qfr8TVEZoNtTA-rTL4_t6nd946HInCbEZNVUUrT1ZHmd_H8msrzwl67NmpxAgdp2fnWX5wyHCua5wH1xM_YNjc7NK8mo61MmH-F4vwLYv_Hp7-BT-7MHR6D90N-BGnvYj30ZGrH6Bbi7BD_hD9nNd2mac4z9ckXcXR51aTr9WS8Kn49f2HaKJsdSEp1t-qFlc1aasNmALWdYGHGkkMMnT1l9j6zh0bAKMF2W9xx0zceUr8aacL1xIfAQs8W85wT75bhv9_73EKR1yD911OLu4lutiFdj6P0OXph_UsI6EPA7FMsD0RugAYaTTnrpTOUMscA-QmueHxZGwnGgKenNIilrKkklKTOCqKQpgiMXwMM_4Yjept7Z4iTEUJAMlKGxsDUNFz9cMNWGLkRJfxeHqC6DD9ygaSct8rY6OGbLQvCjSmvMZUr7ET9O4wpOkZOm66mA86VX-YmYIIctOwN4P-FXx-fk9F12573SpYsXrrkxREf9IbxkEKNgHsBC_57P8e-hrdztaLuZqf5efP0R1_ps8TfoFG-921ewloaG9eBWv_DaAyA-I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNA+NNT-AS1%2Fhsa-miR-485-5p%2FHSP90+axis+in-silico+and+clinical+prospect+correlated-to+histologic+grades-based+CRC+stratification%3A+A+step+toward+ncRNA+Precision&rft.jtitle=Pathology%2C+research+and+practice&rft.au=El-Sheikh%2C+Nada+M&rft.au=Abulsoud%2C+Ahmed+I&rft.au=Fawzy%2C+Amal&rft.au=Wasfey%2C+Eman+F&rft.date=2023-07-01&rft.eissn=1618-0631&rft.volume=247&rft.spage=154570&rft_id=info:doi/10.1016%2Fj.prp.2023.154570&rft_id=info%3Apmid%2F37244051&rft.externalDocID=37244051 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0344-0338&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0344-0338&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0344-0338&client=summon |